Roberts Jodie I, Jewett Gordon A E, Tellier Raymond, Couillard Philippe, Peters Steven
Division of Neurology, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Alberta, Canada.
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada.
Neurohospitalist. 2021 Jan;11(1):66-70. doi: 10.1177/1941874420943031. Epub 2020 Jul 22.
Untreated herpes simplex virus type 1 (HSV-1) encephalitis is associated with high mortality. Missed cases can have devastating consequences. Detection of HSV-1 in cerebrospinal fluid (CSF) with polymerase chain reaction (PCR) is reported to have high sensitivity and specificity and is considered the diagnostic gold standard for HSV-1 encephalitis. In this article, we report a case of autopsy-confirmed HSV-1 encephalitis where CSF PCR returned negative on 2 occasions. A 64-year-old man presented with fever, left-sided weakness, and altered level of consciousness. Magnetic resonance imaging demonstrated right mesial temporal lobe diffusion restriction and electroencephalography showed right lateralized periodic discharges. Lumbar puncture was performed on day 1 for which CSF PCR returned negative for HSV-1. Empiric antiviral and antibiotic treatments were continued due to high clinical suspicion of HSV-1 encephalitis. Repeat lumbar puncture on day 5 was unchanged and empiric treatments were discontinued. On day 13, he developed status epilepticus requiring intensive care unit admission. A third CSF sample returned positive for HSV-1. Acyclovir was restarted but he continued to clinically worsen and supportive care was withdrawn. Autopsy confirmed widespread HSV-1 meningoencephalitis. Negative CSF PCR should be interpreted with caution in cases where there is high clinical suspicion of HSV-1 encephalitis. Current guidelines suggest repeating CSF HSV-1 PCR within 3 to 7 days in suspicious cases while continuing empiric therapy. However, missed cases can occur even with repeated testing. Empiric treatment with acyclovir should be considered in cases with high clinical suspicion of HSV-1 encephalitis, while investigations for alternate treatable diagnoses are continued.
未经治疗的1型单纯疱疹病毒(HSV-1)脑炎与高死亡率相关。漏诊病例可能会产生灾难性后果。据报道,采用聚合酶链反应(PCR)检测脑脊液(CSF)中的HSV-1具有高灵敏度和特异性,被认为是HSV-1脑炎的诊断金标准。在本文中,我们报告了一例经尸检确诊的HSV-1脑炎病例,该病例的脑脊液PCR两次结果均为阴性。一名64岁男性出现发热、左侧肢体无力和意识水平改变。磁共振成像显示右侧颞叶内侧弥散受限,脑电图显示右侧周期性放电。第1天进行了腰椎穿刺,脑脊液PCR检测HSV-1结果为阴性。由于高度怀疑为HSV-1脑炎,继续进行经验性抗病毒和抗生素治疗。第5天重复腰椎穿刺结果无变化,经验性治疗停药。第13天,他发生癫痫持续状态,需要入住重症监护病房。第三次脑脊液样本HSV-1检测呈阳性。重新开始使用阿昔洛韦,但他的临床病情继续恶化,于是停止了支持治疗。尸检证实为广泛的HSV-1脑膜脑炎。对于高度怀疑HSV-1脑炎的病例,脑脊液PCR结果为阴性时应谨慎解读。当前指南建议在可疑病例中于3至7天内重复进行脑脊液HSV-1 PCR检测,同时继续进行经验性治疗。然而,即使重复检测也可能出现漏诊病例。对于高度怀疑HSV-1脑炎的病例,应考虑使用阿昔洛韦进行经验性治疗,同时继续排查其他可治疗的诊断。